Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c00822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Mingming Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Activating Nrf2 through inhibiting Keap1 has been proven to alleviate oxidative stress and related diseases, including nonalcoholic fatty liver disease (NAFLD). Traditional Keap1 inhibitors could not avoid the "off-target" effects, but using proteolysis targeting chimera (PROTAC) technology to induce Keap1 degradation might be an effective strategy to find potential NAFLD improving agents. Thus, several PROTACs were designed and synthesized by harnessing CDDO as the Keap1 ligand in this study. PROTAC I-d exhibited optimal Keap1 degradation activity, which could increase the Nrf2 level and alleviate oxidative stress in free fatty acid-induced AML12 cells and the liver of mice fed with a methionine-choline-deficient diet. Moreover, compared with CDDO, PROTAC I-d displayed significant advantages in inhibiting hepatic steatosis, steatohepatitis, and fibrosis in the in vivo and in vitro models of NAFLD. In addition, PROTAC I-d also showed lower in vivo toxicity than CDDO. All these results suggested that PROTAC I-d might be a potential improving agent for NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
- School of Pharmacy, Jiangsu Food and Pharmaceutical Science College, Huaian 223003, China.
ORCID-Profile: Li Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qi, M., Zhong, H., Cheng, Z., Chen, S., Xiao, H., Shang, J., Chen, L., & Sun, J. (2023). Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00822
Vancouver
Qi M, Zhong H, Cheng Z, Chen S, Xiao H, Shang J, et al. Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00822
BibTeX
@article{Qi2023,
author = {Qi, Mingming and Zhong, Hui and Cheng, Zhaoyan and Chen, Shujie and Xiao, Han and Shang, Jing and Chen, Li and Sun, Jianbo},
title = {Discovery of NAFLD-Improving Agents by Promoting the Degradation of Keap1},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c00822}
}
EUVIMED